Great to have someone of Mark Parsons calibre and experience working with Dennis Cordato at the Ingham Institute on supervising the pivotal trial.
Interesting presentation by Professor Parsons - from 6 minutes - on his involvement in stroke clinical trials:
Ann: EMVision Commences Clinical Trial, page-22
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.00 |
Change
0.215(12.0%) |
Mkt cap ! $171.0M | |||
| Open | High | Low | Value | Volume |
| $1.87 | $2.10 | $1.87 | $173.9K | 88.05K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2629 | $1.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.00 | 16494 | 2 |
View Market Depth
| Last trade - 15.59pm 12/11/2024 (20 minute delay) ? |
| EMV (ASX) Chart |